Abstract: The present invention relates to compounds capable of acting as androgen receptor antagonists, pharmaceutical formulations containing the same, and methods of use thereof. Such uses include, but are not limited to, use as antitumor agents, particularly for the treatment of cancers such as colon, skin and prostate cancer and to induce androgen receptor antagonist activity in a subject afflicted with an androgen-related affliction. Examples of androgen-related afflictions include, but are not limited to, baldness, hirsutism, behavioral disorders, acne, and uninhibited spermatogenesis wherein inhibition of spermatogenesis is so desired.

Abstract: The present invention relates to compounds capable of acting as androgen receptor antagonists, pharmaceutical formulations containing the same, and methods of use thereof. Such uses include, but are not limited to, use as antitumor agents, particularly for the treatment of cancers such as colon, skin and prostate cancer and to induce androgen receptor antagonist activity in a subject afflicted with an androgen-related affliction. Examples of androgen-related afflictions include, but are not limited to, baldness, hirsutism, behavioral disorders, acne, and uninhibited spermatogenesis wherein inhibition of spermatogenesis is so desired.

Abstract: The present invention relates to compounds capable of acting as androgen receptor antagonists, pharmaceutical formulations containing the same, and methods of use thereof. Such uses include, but are not limited to, use as antitumor agents, particularly for the treatment of cancers such as colon, skin and prostate cancer and to induce androgen receptor antagonist activity in a subject afflicted with an androgen-related affliction. Examples of androgen-related afflictions include, but are not limited to, baldness, hirsutism, behavioral disorders, acne, and uninhibited spermatogenesis wherein inhibition of spermatogenesis is so desired.

Abstract: The present invention relates to compounds capable of acting as androgen receptor antagonists, pharmaceutical formulations containing the same, and methods of use thereof. Such uses include, but are not limited to, use as antitumor agents, particularly for the treatment of cancers such as colon, skin and prostate cancer and to induce androgen receptor antagonist activity in a subject afflicted with an androgen-related affliction. Examples of androgen-related afflictions include, but are not limited to, baldness, hirsutism, behavioral disorders, acne, and uninhibited spermatogenesis wherein inhibition of spermatogenesis is so desired.

Abstract: The present invention relates to compounds capable of acting as androgen receptor antagonists, pharmaceutical formulations containing the same, and methods of use thereof. Such uses include, but are not limited to, use as antitumor agents, particularly for the treatment of cancers such as colon, skin and prostate cancer and to induce androgen receptor antagonist activity in a subject afflicted with an androgen-related affliction. Examples of androgen-related afflictions include, but are not limited to, baldness, hirsutism, behavioral disorders, acne, and uninhibited spermatogenesis wherein inhibition of spermatogenesis is so desired.

Abstract: The present invention relates to compounds capable of acting as androgen receptor antagonists, pharmaceutical formulations containing the same, and methods of use thereof. Such uses include, but are not limited to, use as antitumor agents, particularly for the treatment of cancers such as colon, skin and prostate cancer and to induce androgen receptor antagonist activity in a subject afflicted with an androgen-related affliction. Examples of androgen-related afflictions include, but are not limited to, baldness, hirsutism, behavioral disorders, acne, and uninhibited spermatogenesis wherein inhibition of spermatogenesis is so desired.

Abstract: The present invention relates to compounds capable of acting as androgen receptor antagonists, pharmaceutical formulations containing the same, and methods of use thereof. Such uses include, but are not limited to, use as antitumor agents, particularly for the treatment of cancers such as colon, skin and prostate cancer and to induce androgen receptor antagonist activity in a subject afflicted with an androgen-related affliction. Examples of androgen-related afflictions include, but are not limited to, baldness, hirsutism, behavioral disorders, acne, and uninhibited spermatogenesis wherein inhibition of spermatogenesis is so desired.

Abstract: The present invention relates to compounds capable of acting as androgen receptor antagonists, pharmaceutical formulations containing the same, and methods of use thereof. Such uses include, but are not limited to, use as antitumor agents, particularly for the treatment of cancers such as colon, skin and prostate cancer and to induce androgen receptor antagonist activity in a subject afflicted with an androgen-related affliction. Examples of androgen-related afflictions include, but are not limited to, baldness, hirsutism, behavioral disorders, acne, and uninhibited spermatogenesis wherein inhibition of spermatogenesis is so desired.

Abstract: The present invention relates to compounds capable of acting as androgen receptor antagonists, pharmaceutical formulations containing the same, and methods of use thereof. Such uses include, but are not limited to, use as antitumor agents, particularly for the treatment of cancers such as colon, skin and prostate cancer and to induce androgen receptor antagonist activity in a subject afflicted with an androgen-related affliction. Examples of androgen-related afflictions include, but are not limited to, baldness, hirsutism, behavioral disorders, acne, and uninhibited spermatogenesis wherein inhibition of spermatogenesis is so desired.

Abstract: The present invention relates to compounds capable of acting as androgen receptor antagonists, pharmaceutical formulations containing the same, and methods of use thereof. Such uses include, but are not limited to, use as antitumor agents, particularly for the treatment of cancers such as colon, skin and prostate cancer and to induce androgen receptor antagonist activity in a subject afflicted with an androgen-related affliction. Examples of androgen-related afflictions include, but are not limited to, baldness, hirsutism, behavioral disorders, acne, and uninhibited spermatogenesis wherein inhibition of spermatogenesis is so desired.

Abstract: A pressure-contact terminal includes: a contact portion (21); and a pressure-contact portion (32) which has a bottom plate, a pair of side plates formed by bending from the bottom plate in the same direction, and at least a pair of pressure-contact plates (34, 35) formed to stand from the pair of side plates above the bottom plate and to face each other. In the construction, the pressure-contact plates (34, 35) include: electric wire contact portions (34A, 35A) formed by bending which have contact faces (34G, 35G) to be in contact with a core of a covered electric wire; and cover cutting-off portions (34B, 35B ) formed on upper portions of the electric wire contact portions (34A, 35A ) to cut and remove the cover portion of the covered electric wire.

Abstract: There is provided an insulation displacing terminal having a first engagement part, a housing which has a side wall defining a groove for accommodating the insulation displacing terminal. The side wall has a second engagement part engaging with the first engagement part for locking. The first engagement part is an opening part, and the second engagement part is a projection.

Abstract: A pressure-contact terminal includes: a contact portion formed on a tip end side of the pressure-contact terminal; and an electric wire connecting portion formed on a rear end side of the pressure-contact terminal have a bottom plate and a pair of side plates which are formed with a plurality of pairs of pressure-contact portions. In the construction, at least a pair of pressure-contact portions of the plurality of pairs of the pressure-contact portions has a pair of pressure-contact blades. Each of the pair of pressure-contact blades includes: a pressure-contact blade main body cut and bent up from the side plates; a blade portion formed on an outer periphery of the pressure-contact blade main body to cut a cover portion of a covered electric wire; a contact portion continuously formed from the blade portion to be in contact with a core of the covered electric wire; and a core retaining portion for retaining the core.

Abstract: A pressure contact terminal includes a bottom plate, a pair of side plates rising from both sides of the bottom plate in same direction and a plurality of pressure contact cutting edges. The pressure contact cutting edges are formed in a manner such that a pair of pressure contact plates are projected from the pair of the side plates so as to face each other. The pressure contact cutting edges formed with a plurality of pressure contact slots into which a covered electric wire is press-fitted. The plurality of pressure contact cutting edges contains at least two wide pressure contact cutting edges having the pressure contact slots with wide width and a narrow pressure contact cutting edge having the pressure contact slot with narrower width than that of the pressure contact slots of the wide pressure contact cutting edges. The narrow pressure contact cutting edge is arranged between the wide pressure contact cutting edges in an axial direction of the covered electric wire.